Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans

British Journal of Pharmacology

Volumn 172, Issue 13, 2015, Pages 3341-3352

  Arif, Sayqa ^a   Borgognone, Alessandra ^a   Lin, Erica Lai Sze ^a   O'Sullivan, Aine G ^a   Sharma, Vishal ^b   Drury, Nigel E ^a   Menon, Ashvini ^a   Nightingale, Peter ^c   Mascaro, Jorge ^c   Bonser, Robert S ^c   Horowitz, John D ^d   Feelisch, Martin ^e   Frenneaux, Michael P ^f   Madhani, Melanie ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CYANAMIDE; GLYCERYL TRINITRATE; METHEMOGLOBIN; NITRITE; PROPIONALDEHYDE; ALDEHYDE; ALDEHYDE DEHYDROGENASE; ALDH2 PROTEIN, RAT; MITOCHONDRIAL PROTEIN; NITRIC OXIDE DONOR; SPERMINE; SPERMINE NITRIC OXIDE COMPLEX; VASODILATOR AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INACTIVATION; ENZYME INHIBITION; FEMALE; FOREARM BLOOD FLOW; HEART FAILURE; HEMODYNAMICS; HUMAN; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RAT; VASCULAR RESISTANCE; VASODILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY; AGED; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; ARTERY; BLOOD FLOW; DRUG EFFECTS; FOREARM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

AGED; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL; ALDEHYDES; ANIMALS; ARTERIES; CYANAMIDE; FEMALE; FOREARM; HEART FAILURE; HUMANS; HYPOXIA; IN VITRO TECHNIQUES; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; NITRIC OXIDE DONORS; NITRITES; NITROGLYCERIN; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; SPERMINE; VASODILATION; VASODILATOR AGENTS;

EID: 84937428588     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13122     Document Type: Article

References (41)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a) The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b) The Concise Guide to PHARMACOLOGY 2013/14: enzymes. Br J Pharmacol 170: 1797-1867.
3. Angelo M, Singel DJ, Stamler JS, (2006). An S-nitrosothiol (SNO) synthase function of hemoglobin that utilizes nitrite as a substrate. Proc Natl Acad Sci U S A 103: 8366-8371.
4. Badejo AM Jr, Hodnette C, Dhaliwal JS, Casey DB, Pankey E, Murthy SN, et al. (2010). Mitochondrial aldehyde dehydrogenase mediates vasodilator responses of glyceryl trinitrate and sodium nitrite in the pulmonary vascular bed of the rat. Am J Physiol Heart Circ Physiol 299: H819-H826.
5. Bailey JC, Feelisch M, Horowitz JD, Frenneaux MP, Madhani M, (2014). Pharmacology and therapeutic role of inorganic nitrite and nitrate in vasodilatation. Pharmacol Ther 144: 303-320.
6. Baliga RS, Milsom AB, Ghosh SM, Trinder SL, MacAllister RJ, Ahluwalia A, et al. (2012). Dietary nitrate ameliorates pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase. Circulation 125: 2922-2932.
7. Basu S, Grubina R, Huang J, Conradie J, Huang Z, Jeffers A, et al. (2007). Catalytic generation of N2O3 by the concerted nitrite reductase and anhydrase activity of hemoglobin. Nat Chem Biol 3: 785-794.
8. Chen Z, Zhang J, Stamler JS, (2002). Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A 99: 8306-8311.
9. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, et al. (2003). Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9: 1498-1505.
10. Dejam A, Hunter CJ, Tremonti C, Pluta RM, Hon YY, Grimes G, et al. (2007). Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation 116: 1821-1831.
11. DiFabio J, Ji Y, Vasiliou V, Thatcher GR, Bennett BM, (2003). Role of mitochondrial aldehyde dehydrogenase in nitrate tolerance. Mol Pharmacol 64: 1109-1116.
12. Doyle MP, Pickering RA, DeWeert TM, Hoekstra JW, Pater D, (1981). Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem 256: 12393-12398.
13. D'Souza Y, Dowlatshahi S, Bennett BM, (2011). Changes in aldehyde dehydrogenase 2 expression in rat blood vessels during glyceryl trinitrate tolerance development and reversal. Br J Pharmacol 164: 632-643.
14. Furchgott RF, Bhadrakom S, (1953). Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther 108: 129-143.
15. Ghosh SM, Kapil V, Fuentes-Calvo I, Bubb KJ, Pearl V, Milsom AB, et al. (2013). Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential. Hypertension 61: 1091-1102.
16. Gladwin MT, Shelhamer JH, Schechter AN, Pease-Fye ME, Waclawiw MA, Panza JA, et al. (2000). Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A 97: 11482-11487.
17. Golwala NH, Hodenette C, Murthy SN, Nossaman BD, Kadowitz PJ, (2009). Vascular responses to nitrite are mediated by xanthine oxidoreductase and mitochondrial aldehyde dehydrogenase in the rat. Can J Physiol Pharmacol 87: 1095-1101.
18. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, et al. (2009). Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 119: 1661-1670.
19. Huellner MW, Schrepfer S, Weyand M, Weiner H, Wimplinger I, Eschenhagen T, et al. (2008). Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veins. FASEB J 22: 2561-2568.
20. Huffman JC, Stern TA, (2003). Disulfiram use in an elderly man with alcoholism and heart disease: a discussion. Prim Care Companion J Clin Psychiatry 5: 41-44.
21. Irvine JC, Favaloro JL, Widdop RE, Kemp-Harper BK, (2007). Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae. Hypertension 49: 885-892.
22. Johansson B, (1992). A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites. Acta Psychiatr Scand Suppl 369: 15-26.
23. Keith RA, Burkman AM, Sokoloski TD, Fertel RH, (1982). Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J Pharmacol Exp Ther 221: 525-531.
24. Kollau A, Hofer A, Russwurm M, Koesling D, Keung WM, Schmidt K, et al. (2005). Contribution of aldehyde dehydrogenase to mitochondrial bioactivation of nitroglycerin: evidence for the activation of purified soluble guanylate cyclase through direct formation of nitric oxide. Biochem J 385: 769-777.
25. Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC, Juvonen RO, et al. (2012). Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol Rev 64: 520-539.
26. Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, Weitzberg E, (2006). Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med 355: 2792-2793.
27. Li H, Cui H, Kundu TK, Alzawahra W, Zweier JL, (2008). Nitric oxide production from nitrite occurs primarily in tissues not in the blood: critical role of xanthine oxidase and aldehyde oxidase. J Biol Chem 283: 17855-17863.
28. Lundberg JO, Carlstrom M, Larsen FJ, Weitzberg E, (2011). Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc Res 89: 525-532.
29. Mackenzie IS, Maki-Petaja KM, McEniery CM, Bao YP, Wallace SM, Cheriyan J, et al. (2005). Aldehyde dehydrogenase 2 plays a role in the bioactivation of nitroglycerin in humans. Arterioscler Thromb Vasc Biol 25: 1891-1895.
30. Madhani M, Scotland RS, MacAllister RJ, Hobbs AJ, (2003). Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br J Pharmacol 139: 1289-1296.
31. Maher AR, Milsom AB, Gunaruwan P, Abozguia K, Ahmed I, Weaver RA, et al. (2008). Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation 117: 670-677.
32. Maher AR, Arif S, Madhani M, Abozguia K, Ahmed I, Fernandez BO, et al. (2013). Impact of chronic congestive heart failure on pharmacokinetics and vasomotor effects of infused nitrite. Br J Pharmacol 169: 659-670.
33. Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J, (2012). Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol 60: 1455-1469.
34. Ormerod JO, Ashrafian H, Maher AR, Arif S, Steeples V, Born GV, et al. (2011). The role of vascular myoglobin in nitrite-mediated blood vessel relaxation. Cardiovasc Res 89: 560-565.
35. Paneni F, Osto E, Costantino S, Mateescu B, Briand S, Coppolino G, et al. (2013). Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunction. Circulation 127: 1229-1240.
36. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al.; NC-IUPHAR (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucl Acids Res 42 (Database Issue): D1098-D1106.
37. Perlman DH, Bauer SM, Ashrafian H, Bryan NS, Garcia-Saura MF, Lim CC, et al. (2009). Mechanistic insights into nitrite-induced cardioprotection using an integrated metabolomic/proteomic approach. Circ Res 104: 796-804.
38. Philpott A, Sage P, Stafford I, Murphy G, de la Lande IS, Stuklis R, et al. (2007). Dissociation of aldehyde dehydrogenase activity from nitrate effect, bioconversion, and tolerance in humans.
39. Pinder AG, Pittaway E, Morris K, James PE, (2009). Nitrite directly vasodilates hypoxic vasculature via nitric oxide-dependent and -independent pathways. Br J Pharmacol 157: 1523-1530.
40. Tiso M, Tejero J, Basu S, Azarov I, Wang X, Simplaceanu V, et al. (2011). Human neuroglobin functions as a redox-regulated nitrite reductase. J Biol Chem 286: 18277-18289.
41. Totzeck M, Hendgen-Cotta UB, Luedike P, Berenbrink M, Klare JP, Steinhoff HJ, et al. (2012). Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation. Circulation 126: 325-334.